Date Time
2020: an unforgettable year
2020 has been an unforgettable year, with the biotech community’s strong contribution to the global healthcare system and to Australia’s economy shining brightly through the many challenges being faced professionally and personally.
While times have been testing, there has been giant strides for Australian life sciences. Most critically for our industry, after more than four years of advocacy, certainty was delivered after the majority of the proposed changes to the Research and Development Tax Incentive (RDTI) were dropped; Australia embraced telehealth as a standard consultation method, thereby increasing accessibility to healthcare; the sector engaged enthusiastically through AusBiotech’s virtual platforms and first virtual conference: AusBiotech + Invest 2020; goals for the Biotech Blueprint, the sector’s decadal framework, were developed; and the AusBiotech-led Regenerative Medicine (RM) Catalyst Project has begun preparing for Au